Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue

Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge

(2016) Natalie Fischer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crohn's disease-derived monocytes fail to induce Paneth cell defensins

(2015) Lioba F. Courth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

(2014) C. Felice et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA

(2014) Roberto Lande et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators

(2014) Hui Yang et al.   FASEB JOURNAL

Epigenetic and genetic features of 24 colon cancer cell lines

(2013) D Ahmed et al.   Oncogenesis

Inflammatory bowel disease: an impaired barrier disease

(2012) Simon Jäger et al.   LANGENBECKS ARCHIVES OF SURGERY

Unknown

(2011) Rainer Glauben et al.   MOLECULAR MEDICINE

Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria

(2011) L Yin et al.   Mucosal Immunology

Probiotics in Inflammatory Bowel Diseases and Associated Conditions

(2011) David Mack   Nutrients

Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria

(2010) Lei Yin et al.   BMC IMMUNOLOGY

Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway

(2010) Bo Huang et al.   CELLULAR SIGNALLING

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

(2010) M. Schlee et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Nonhistone protein acetylation as cancer therapy targets

(2010) Brahma N Singh et al.   Expert Review of Anticancer Therapy

Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring

(2010) Frédérik Oger et al.   JOURNAL OF MEDICINAL CHEMISTRY

Expression of Human Beta-Defensins in Children with Chronic Inflammatory Bowel Disease

(2010) Matthias Zilbauer et al.   PLoS One

Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans

(2009) M Möndel et al.   Mucosal Immunology

Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease

(2009) Marian C. Aldhous et al.   PLoS One

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

(2008) Nagma Khan et al.   BIOCHEMICAL JOURNAL

IL-12, IL-23, and IL-27 enhance human β-defensin-2 production in human keratinocytes

(2008) Naoko Kanda et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The dietary histone deacetylase inhibitor sulforaphane induces human β-defensin-2 in intestinal epithelial cells

(2008) Markus Schwab et al.   IMMUNOLOGY

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

(2008) J Wehkamp et al.   Mucosal Immunology